Sens. Cassidy, Hassan eye site-neutral payments policy
Sens. Dr. Bill Cassidy (R-La.) and Maggie Hassan (D-N.H.) aim to craft legislation constraining Medicare spending on outpatient care.
Related Articles
How scope creep is pushing beyond primary care
Dermatology, emergency medicine and anesthesia are just three specialty areas in which undermining physician-led care is endangering patient safety.
SPN-820 Decreases Depressive Symptoms Within Hours of First Dose in Phase 2a Trial
In a recent phase 2a trial, SPN-820, a novel intracellular moderator of mTORC1, decreased suicidal ideation by 80%.
Cardinal Health lifts annual profit outlook on strength in specialty medicines unit
Cardinal Health raised its fiscal 2025 adjusted profit forecast on Friday as strong demand for costly specialty medicines and branded drugs drove sales at its…
Elevance sues over Medicare Advantage star ratings
Elevance Health follows UnitedHealth Group, Humana and Centene in challenging the 2025 Medicare Advantage quality scores in court.
Dementia vs. Alzheimer’s: The Difference
People often conflate dementia and Alzheimer’s disease, but they’re not always one and the same. A neuropsychologist explains how there are various kinds of dementia…
What’s New and What To Watch For in the Upcoming ACA Open Enrollment Period – KFF Health News
This year’s start date in most states is Nov. 1, and consumers may encounter new scams as well as important rule changes.
Link Discovered Between Excess Niacin and Cardiovascular Disease
Cleveland Clinic researchers have identified a new pathway linked to excess niacin levels that contributes to cardiovascular disease independent of traditional risk factors. A newly…
Ransomware still the #1 cyber threat
A new report from Check Point Research shows that ransomware remains the top cyber threat, with RansomHub emerging as the fastest-growing group, operating through Ransomware-as-a-Service…
One in 20 new Wikipedia pages seem to be written with the help of AI
Just under 5 per cent of the Wikipedia pages in English that have been published since ChatGPT’s release seem to include AI-written content
US FDA warns against California facility making compounded weight-loss drugs
The U.S. Food and Drug Administration on Friday warned against the use of compounded drugs, including versions of popular weight-loss treatments, made by a California-based…